Background: Pharmacovigilance, defined by the World Health Organisation as 'the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem' plays a key role in ensuring that patients receive safe drugs. Our knowledge of a drug's adverse reactions can be increased by various means, including spontaneous reporting, intensive monitoring and database studies. New processes, both at a regulatory and a scientific level, are being developed with the aim of strengthening pharmacovigilance. On a regulatory level, these include conditional approval and risk management plans; on a scientific level, transparency and increased patient involvement are two important elements. Objective: To review and discuss various aspects of pharmacovigilance, including new methodolgical developments. © 2008 Springer-Verlag.
CITATION STYLE
Härmark, L., & Van Grootheest, A. C. (2008, August). Pharmacovigilance: Methods, recent developments and future perspectives. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-008-0475-9
Mendeley helps you to discover research relevant for your work.